X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (31) 31
male (27) 27
index medicus (21) 21
middle aged (19) 19
aged (18) 18
urology & nephrology (18) 18
prostate cancer (15) 15
female (13) 13
surgery (13) 13
aged, 80 and over (11) 11
cancer (11) 11
adult (9) 9
medicine, general & internal (8) 8
radical prostatectomy (8) 8
article (7) 7
care and treatment (7) 7
expression (7) 7
mortality (7) 7
oncology (7) 7
patients (7) 7
urology (7) 7
analysis (6) 6
animals (6) 6
biopsy (6) 6
prognosis (6) 6
prostate (6) 6
abridged index medicus (5) 5
medicine (5) 5
medicine, research & experimental (5) 5
research (5) 5
adenocarcinoma (4) 4
apoptosis (4) 4
biomarkers (4) 4
bladder cancer (4) 4
health aspects (4) 4
laparoscopy (4) 4
men (4) 4
metastasis (4) 4
patient outcomes (4) 4
prostate-specific antigen - blood (4) 4
prostatic neoplasms (4) 4
prostatic neoplasms - mortality (4) 4
prostatic neoplasms - pathology (4) 4
quality-of-life (4) 4
retrospective studies (4) 4
studies (4) 4
survival (4) 4
treatment outcome (4) 4
tumors (4) 4
androgens (3) 3
angiogenesis (3) 3
association (3) 3
bladder (3) 3
cancer patients (3) 3
cancer research (3) 3
cancer therapies (3) 3
carcinoma (3) 3
cell line, tumor (3) 3
clinical neurology (3) 3
comorbidity (3) 3
diagnosis (3) 3
follow-up studies (3) 3
gleason score (3) 3
holmium laser enucleation (3) 3
hyperplasia (3) 3
index (3) 3
kidney neoplasms - surgery (3) 3
magnetic resonance imaging (3) 3
mice (3) 3
neoplasm grading (3) 3
neoplasm staging (3) 3
older men (3) 3
pheochromocytoma (3) 3
prostatectomy (3) 3
prostatic neoplasms - blood (3) 3
quality of life (3) 3
risk (3) 3
risk factors (3) 3
robotics (3) 3
time factors (3) 3
trends (3) 3
urinary bladder neoplasms - drug therapy (3) 3
urinary bladder neoplasms - pathology (3) 3
urine (3) 3
veterans (3) 3
active surveillance (2) 2
adjuvant (2) 2
administration, intravesical (2) 2
african americans (2) 2
aging (2) 2
alzheimer-disease (2) 2
analgesics (2) 2
androgen antagonists - adverse effects (2) 2
androgen antagonists - therapeutic use (2) 2
antigens (2) 2
antineoplastic agents, hormonal - adverse effects (2) 2
antineoplastic agents, hormonal - therapeutic use (2) 2
aquablation (2) 2
biochemical recurrence (2) 2
biology (2) 2
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The Lancet, ISSN 0140-6736, 06/2018, Volume 391, Issue 10139, pp. 2525 - 2536
Journal Article
Journal Article
BJU International, ISSN 1464-4096, 01/2019, Volume 123, Issue 1, pp. 106 - 112
Objectives To present early safety and feasibility data from a multicentre prospective study (WATER II) of aquablation in the treatment of symptomatic men with... 
robotics | aquablation | benign prostatic hyperplasia | large prostates | LEARNING-CURVE | SIMPLE PROSTATECTOMY | UROLOGY & NEPHROLOGY | VAPORIZATION | INDEX | TRENDS | HOLMIUM LASER ENUCLEATION | Demography | Adenoma | Prostate | Patients | Hyperplasia | Tamponade
Journal Article
BJU International, ISSN 1464-4096, 08/2019, Volume 124, Issue 2, pp. 321 - 328
Objective To present 6‐month safety and effectiveness data from a multicentre prospective study of aquablation in men with lower urinary tract symptoms (LUTS)... 
prostate surgery | urology | robotics | aquablation | BPH | LUTS | UroBPH | LEARNING-CURVE | UROLOGY & NEPHROLOGY | INDEX | SEXUAL FUNCTION | HOLMIUM LASER ENUCLEATION | Prostate | Robotics | Hypertrophy | Urine | Urinary tract | Patients | Hyperplasia | Benign
Journal Article
Nature Reviews Urology, ISSN 1759-4812, 04/2015, Volume 12, Issue 4, pp. 225 - 235
Multiple clinical trials have demonstrated that intravesical Bacillus Calmette-Guérin (BCG) treatment reduces recurrences and progression in patients with... 
Immunotherapy - methods | Humans | Urinary Bladder Neoplasms - therapy | Benchmarking | Male | Treatment Outcome | Combined Modality Therapy | Administration, Intravesical | BCG Vaccine - therapeutic use | Urinary Bladder Neoplasms - drug therapy | Urinary Bladder Neoplasms - surgery
Journal Article
Journal Article
BMC Cancer, ISSN 1471-2407, 08/2012, Volume 12, Issue 1, p. 371
Journal Article
NATURE REVIEWS UROLOGY, ISSN 1759-4812, 04/2015, Volume 12, Issue 4, pp. 225 - 235
Journal Article
PloS one, ISSN 1932-6203, 2013, Volume 8, Issue 8, p. e72032
Background: Androgen deprivation therapy (ADT) is a common treatment for non-metastatic, low-risk prostate cancer, but a potential side effect of ADT is... 
ALZHEIMER-DISEASE | BRAIN STRUCTURE | MULTIDISCIPLINARY SCIENCES | GREY-MATTER VOLUME | FREE TESTOSTERONE | OLDER MEN | SPATIAL MEMORY | QUALITY-OF-LIFE | ELDERLY-MEN | COGNITIVE FUNCTION | VOXEL-BASED MORPHOMETRY | Memory - drug effects | Neuroimaging | Humans | Middle Aged | Prefrontal Cortex - physiopathology | Male | Motor Cortex - drug effects | Cognitive Dysfunction - physiopathology | Case-Control Studies | Motor Cortex - pathology | Prefrontal Cortex - pathology | Antineoplastic Agents, Hormonal - adverse effects | Magnetic Resonance Imaging | Organ Size - drug effects | Animals | Prefrontal Cortex - drug effects | Antineoplastic Agents, Hormonal - therapeutic use | Androgen Antagonists - therapeutic use | Quality of Life | Aged | Cognitive Dysfunction - chemically induced | Androgen Antagonists - adverse effects | Prostatic Neoplasms - drug therapy | Brain | Cancer patients | Care and treatment | Oncology, Experimental | Metastasis | Research | Cancer | Therapy | High resolution | Memory | Cognitive ability | Mental task performance | Hormones | Cancer therapies | Risk factors | Image acquisition | Metastases | Mens health | Functional magnetic resonance imaging | Target detection | Cortex (prefrontal) | Image resolution | Internal medicine | Brain mapping | Patients | Reaction time task | Quality of life | Androgens | Reaction time | Morphometry | Short term memory | Neurosciences | Parameter estimation | Nuclear magnetic resonance--NMR | Cerebral ventricles | Ventricles (cerebral) | Cortex (motor) | Substantia grisea | Deprivation | Risk groups | Health care policy | Health risks | Gender differences | Radiation therapy | Substantia alba | Medicine | Testosterone | Brain research | Magnetic resonance imaging | Psychiatry | Prostate cancer | Prostate | Nuclear magnetic resonance | NMR
Journal Article
Journal of Investigative Medicine, ISSN 1081-5589, 12/2018, Volume 66, Issue 8, pp. 1142 - 1147
Older men are more likely to have advanced prostate cancer at time of their diagnosis, but whether prostate tumors are inherently (biologically) more... 
biological markers | cancer | aging | MEDICINE, RESEARCH & EXPERIMENTAL | MEDICINE, GENERAL & INTERNAL | MANAGEMENT | ANGIOGENESIS | PROGNOSTIC BIOMARKERS | PROTEIN EXPRESSION | MUTANT P53 | GRADE | OLDER MEN | PATIENT AGE | ASSOCIATION | IMMUNOHISTOCHEMISTRY
Journal Article
The Prostate, ISSN 0270-4137, 03/2018, Volume 78, Issue 4, pp. 294 - 299
Background Distinguishing between low‐ and high‐grade prostate cancers (PCa) is important, but biopsy may underestimate the actual grade of cancer. We have... 
Gleason score | prostate cancer | high grade | biomarkers | active surveillance | PCA3 | INTERNATIONAL-SOCIETY | BIOPSY | RADICAL PROSTATECTOMY | TRIAL | IMPACT | ENDOCRINOLOGY & METABOLISM | UROLOGY & NEPHROLOGY | SCORING SYSTEM | EXPRESSION | Diagnosis | RNA | Prostate cancer | Surgery | Analysis | Urine | Biopsy | Biomarkers | Ribonucleic acid--RNA | Prostate | Cancer | Metastases
Journal Article
Journal of the American College of Surgeons, ISSN 1072-7515, 2008, Volume 207, Issue 3, pp. S96 - S96
Journal Article